Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysisL W Kwak, J Halpern, R A Olshen, et al.
Clinical Lymphoma|January 10, 2002
Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximabY Natkunam, T S Stanton, R A Warnke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Follicular and diffuse mixed small-cleaved and large-cell lymphoma--a clinicopathologic studyE Hu, L M Weiss, R T Hoppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's diseaseS J Horning, R T Hoppe, S L Hancock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's diseaseS J Horning, P T Ang, R T Hoppe, et al.
The New England Journal of Medicine|June 4, 1981
Female reproductive potential after treatment for Hodgkin's diseaseS J Horning, R T Hoppe, H S Kaplan, et al.
Cancer|April 15, 1987
Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphomaS J Horning, L M Weiss, J B Nevitt, et al.
Blood|June 1, 1986
Clinical and phenotypic diversity of T cell lymphomasS J Horning, L M Weiss, G S Crabtree, et al.
Annals of Internal Medicine|August 1, 1988
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trialsS L Hancock, R T Hoppe, S J Horning, et al.
Pageof 10